Ambu gets recommendation from FDA, analyst doubts effect

The FDA recommendation that single-use bronchoscopes are used at US hospitals will have little effect, as US lung specialists gave the same advice over a year ago, says Niels Granholm-Leth, Head of Equity Research at Carnegie.

Photo: Ambu / PR

On Friday, the US Food and Drug Administration (FDA) recommended that doctors at US hospitals use single-use bronchoscopes instead of reusable scopes – one year after the American Lung Association gave the same advice.

Many bronchologists are therefore already using single-use scopes rather than reusable scopes, explains Niels Granholm-Leth, Head of Equity Research at Carnegie.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs